KRAS and familial pancreatic carcinoma: For example, KRAS mutations are found at high rates in lung, colorectal, and pancreatic cancer, and inhibiting KRAS in these cancers causes tumor growth inhibition (Sunaga et al., 2011, Zorde Khvalevsky et al., 2013).